Asset Management One’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-37,786
Closed -$255K 1163
2016
Q3
$255K Sell
37,786
-4,304
-10% -$23.7K ﹤0.01% 1183
2016
Q2
$194K Sell
42,090
-2,736
-6% -$14.1K ﹤0.01% 1205
2016
Q1
$163K Sell
44,826
-10,747
-19% -$54.6K ﹤0.01% 1250
2015
Q4
$422K Sell
55,573
-2,102
-4% -$24.2K 0.01% 1098
2015
Q3
$807K Sell
57,675
-34,502
-37% -$578K 0.01% 923
2015
Q2
$1.5M Sell
92,177
-50,888
-36% -$959K 0.02% 755
2015
Q1
$3.48M Buy
143,065
+13,622
+11% +$281K 0.04% 506
2014
Q4
$2.54M Buy
129,443
+17,830
+16% +$271K 0.03% 619
2014
Q3
$1.77M Buy
+111,613
New +$1.79M 0.02% 643

Other funds holding PRQR

Asset Management One's PRQR Position: Q4 2016 in Review

Asset Management One sold out of ProQR Therapeutics (PRQR) in Q4 2016, closing a stake of 37,786 shares — an estimated $255K sold.

Asset Management One first reported a position in PRQR in Q3 2014 and held it in 9 quarters. The position peaked at $3.48M in Q1 2015. 23 funds tracked by Wall St. Rank hold PRQR as of Q4 2016.

  • Asset Management One reported no remaining ProQR Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 37,786 ProQR Therapeutics shares in Q4 2016, an estimated $255K.
  • Asset Management One first reported a position in ProQR Therapeutics in Q3 2014 and held it in 9 quarters.
  • Asset Management One's ProQR Therapeutics position peaked at $3.48M in Q1 2015.
  • 23 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.